BMT Tandem "Scientific" Meeting
Seaport Ballroom ABC (Manchester Grand Hyatt)
Chairs:
Christopher C. Dvorak, MD
and
Carrie L. Kitko, MD
Disclosures:
C. C. Dvorak,
Nothing To Disclose
C. L. Kitko,
Nothing To Disclose
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Justine Kahn, MD, New York Presbyterian Hospital- Columbia University Medical Center;
Naima Al Mulla, M.D., New York Presbyterian Hospital- Columbia University Medical Center;
Mahvish Qureshi, MD, New York Presbyterian Hospital- Columbia University Medical Center;
Grace Kim, New York Presbyterian Hospital- Columbia University Medical Center;
Zhezhen Jin, PhD, Columbia University;
Monica Bhatia, MD, Columbia University;
Esra Karamehmet, Columbia University Medical Center;
James Garvin, MD, PhD, Columbia University;
Diane George, MD, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Prakash Satwani, MD, Columbia University Medical Center
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Orly Klein, MD, The Johns Hopkins University School of Medicine;
Diana Steppan, MD, The Johns Hopkins University School of Medicine;
Nancy Robey, PA, Johns Hopkins Hospital;
Christopher Gamper, MD, PhD, Johns Hopkins Hospital;
David Loeb, MD, PhD, Johns Hopkins Hospital;
Elias Zambidis, MD, PhD, Johns Hopkins University School of Medicine;
Kenneth R. Cooke, MD, Johns Hopkins University;
Allen Chen, MD, PhD, MHS, Johns Hopkins Hospital;
Heather J. Symons, MD, MHS, The Johns Hopkins University School of Medicine
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital;
Lisa Forbes, MD, Baylor College of Medicine, Texas Children's Hospital;
William Shearer, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Howard Rosenblatt, MD, Dell Children's Medical Center and SFC;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Swati Naik, MD, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Nabil M Ahmed, MD, MPH, Baylor College of Medicine, Texas Children's Hospital;
Ghadir Sasa, MD, Baylor College of Medicine, Texas Children's Hospital;
Malcolm Brenner, MD, PhD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Ann M. Leen, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Imelda C Hanson, MD, Baylor College of Medicine, Texas Children's Hospital;
Robert A. Krance, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Tom Leemhuis, PhD, Hoxworth Blood Center;
David A. Williams, MD, Boston Children's Hospital;
Leslie E. Lehmann, MD, Dana-Farber Cancer Institute;
Eva Guinan, MD, Dana-Farber Cancer Institute;
David A. Margolis, MD, Medical College of Wisconsin;
K. Scott Baker, MD, MS, Fred Hutchinson Cancer Research Center;
Elizabeth Klein, Memorial Sloan Kettering Cancer Center;
Farid Boulad, MD, Memorial Sloan Kettering Cancer Center
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Prakash Satwani, MD, Columbia University Medical Center;
Kwang Woo Ahn, PhD, Medical College of Wisconsin;
Jeanette Carreras, MPH, Medical College of Wisconsin;
David G. Maloney, MD, PhD, Fred Hutchinson Cancer Research Center;
Anna Sureda, MD, Institut Català d'Oncologia, Hospital Duran i Reynals;
Sonali M. Smith, MD, University of Chicago;
Mehdi Hamadani, MD, Medical College of Wisconsin
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Ashok Srinivasan, MD, St.Jude Children's Research Hospital;
Saumini Srinivasan, MD, Division of Pulmonology;
Sudeep Sunthankar, BS, Medical University of South Carolina;
Anusha Sunkara, MS, St.Jude Children's Research Hospital;
Guolian Kang, PhD, St. Jude Children's Research Hospital;
Dennis Stokes, MD, University of Tennessee Health Science Center;
Wing Leung, MD, PhD, St. Jude Children's Research Hospital
![[Visit Client Website]](images/banner.gif)